Dr Magali Gary-Bobo, CR CNRS and co-director of “Glyco and Nanovectors for Therapeutic Targeting” team in IBMM (director: P Dumy). She is co-inventor of 7 patents and co-authors of 119 publications. She has developed an expertise in the fields of photodynamic therapy for cancers and particularly on photoactivable nanoparticles (in near infra-red area) for cancer targeting, imaging and therapy. She is also co-founder of NanoMedSyn company which develops targeted therapies against cancers and rare diseases.